AVAH Aveanna Healthcare Holdings, Inc. Insider Trading

AVAH 10% Owner Robert M Jr Williams dumps 3.00M shares across 3 sales for $24.0M at $8.01, cutting stake by -94.0%

Robert M Jr Williams filed 3 separate sales totaling 3,000,000 shares for $24,030,000.00 at a blended average price of $8.01, reducing his holdings from 3.19M shares to just 190,130 shares — a -94.0% reduction in his pre-transaction position. This filing comes as AVAH's current price sits at $9.27, up +43.3% over the past 30 days and +45.3% over 90 days, meaning the 3 transactions were executed well below today's market price. His cross-ticker track record across 11 prior sells shows an average 90-day return of +12.0% and a 90-day well-timed rate of 37.50%, suggesting his prior sells have generally not preceded stock declines. At AVAH specifically, his 2 measurable prior sells — both on 2025-10-24 — showed 90-day returns of -0.9%, which by the FACTS scoring methodology counts as well-timed at that horizon. The near-complete exit of his position, combined with AVAH's strong recent price momentum and a P/E of 8.35 against quarterly net income of $41,653,000.00, makes the scale and timing of this disposition notable for investors to monitor.

10% owner Paul R Vigano sold 3,000,000 shares (94.0% of pre-transaction holdings) at $8.01 on 2026-06-30 for $24,030,000.00

Paul R Vigano, a 10% owner, executed three separate sales totaling 3,000,000 shares at $8.01 on 2026-06-30 for $24,030,000.00, reducing his holdings from 3.19M shares to 190.1K shares (a 94.0% reduction in pre-transaction holdings). The sale occurred when AVAH stock was trading 10.2% below its 52-week high of $10.32, and notably the stock has risen 43.3% over the 30 days following the transaction and 45.3% over 90 days, suggesting this exit was poorly timed relative to subsequent price appreciation. His prior AVAH sales in October 2025 achieved a 90-day negative return of -0.9%, indicating better timing on that occasion; however, his cross-ticker track record shows an average 90-day return of +12.0% after sells, which is also poorly timed (stock rose after the sales). This near-complete exit by a principal shareholder during a period of strong fundamental performance ($647.9M quarterly revenue, +20.2% annual growth, $41.7M net income, P/E of 8.35) represents a material reduction in insider alignment and may signal a structural rebalancing of this shareholder's concentrated position.

J.H. Whitney Equity Partners VII sold 2,419,035 shares of AVAH at $8.01; retains 10,112,123 shares post-sale.

J.H. Whitney Equity Partners VII, a 10% owner, executed a sale of 2,419,035 shares at $8.01 on 2026-06-30, reducing holdings by 19.3% from 12,531,158 shares to 10,112,123 shares and raising $19,376,470.35. At the prior trade on 2026-06-03, the insider also sold, and at AVAH specifically, the insider's track record shows 1 of 4 measurable prior sales (25%) resulted in negative 90-day returns, indicating generally poor timing discipline at this ticker. The stock has climbed +43.3% over the 30 days following this sale and +45.3% over 90 days, suggesting the June sale was poorly timed relative to subsequent price action. AVAH trades at a P/E of 8.35 with $647.9M in quarterly revenue and 20.2% annual growth, offering limited valuation cushion, yet the post-sale rally indicates the market has repriced the stock upward after the insider's exit.

10% Owner Robert M Jr Williams sells 1,000,000 shares of AVAH at $8.00 for $8,000,000.00; holdings drop 80.3%

Robert M Jr Williams, a 10% owner, executed 3 separate sales totaling 1,000,000 shares for $8,000,000.00 on 2026-06-24, reducing his holdings from 1.25M to 245.3K shares (a -80.3% reduction). This represents a substantial liquidation by a major shareholder at $8.00 per share, while the current price stands at $8.56. Within the same ticker at AVAH, his prior 2 measurable sales on 2025-10-24 both registered negative 90-day returns (-0.9%), suggesting a pattern of well-timed selling at this company. His cross-ticker track record shows 11 prior sells with a 90d well-timed rate of 37.50%, indicating mixed execution on timing. The stock is down -17.0% from its 52-week high but up +36.1% over the last 90 days, creating an ambiguous backdrop for the divestiture's significance.

10% owner J.H. Whitney Equity Partners VII sells 919,389 shares of AVAH at $8.00 for $7,355,112; holdings drop to 12,531,158 shares (-6.8%)

J.H. Whitney Equity Partners VII, a significant 10% stakeholder, sold 919,389 shares at $8.00 on 2026-06-24, reducing its position by -6.8% to 12,531,158 shares. This marks the second sale in 21 days, following a prior sale on 2026-06-03; the earlier transaction's 30-day and 90-day outcomes remain unmeasurable. Across the insider's five prior sales at AVAH, only 1 of 4 prior sells were well-timed at the 90-day mark, suggesting a mixed track record at timing exits in this stock. The current share price of $8.56 stands -17.0% from the 52-week high of $10.32, and AVAH trades at a P/E of 7.71 with $647,915,000.00 in latest-quarter revenue and +20.2% annual revenue growth, indicating the stock has declined from peak levels despite solid underlying growth metrics.

10% owner Paul R Vigano sold 1,000,000 shares of AVAH for $8,000,000 on 2026-06-24, reducing stake by 80.3%.

Paul R Vigano, a 10% owner of Aveanna Healthcare Holdings, Inc., executed 3 separate sales totaling 1,000,000 shares for $8,000,000 on 2026-06-24, at a blended average price of $8.00. This transaction reduced his holdings from 1,245,251 shares to 245,251 shares, representing an 80.3% reduction in his stake. The sale occurred when the stock was trading 17.0% below its 52-week high of $10.32, though it has appreciated 16.6% over the preceding 30 days and 36.1% over 90 days. Across his cross-ticker trading history, his prior sells have been well-timed at the 90-day mark 37.50% of the time with an average 90-day return of +12.0%, while his same-ticker history at AVAH shows 2 prior sells from October 2025 that were both well-timed with negative 90-day returns (-0.9%). The magnitude and timing of this concentrated sale warrants close attention to whether it reflects strategic realignment of a major shareholder position or other considerations affecting the company's outlook.

10% owner Paul Vigano sells 7,000,000 shares (96.5% of holdings) at $6.24 for $43,680,000

Paul Vigano, a 10% beneficial owner of Aveanna Healthcare, executed 3 separate sales totaling 7,000,000 shares for $43,680,000 on 2026-06-03, reducing his stake from 7,252,899 shares to 252,899 shares. This represents a near-complete liquidation of his position at $6.24 per share, when the stock currently trades at $6.66. Vigano's cross-ticker track record shows his 8 prior sells averaged poorly-timed exits (37.50% well-timed rate), though at AVAH specifically, 3 of 5 prior sales were well-timed at the 90-day mark. The company trades at a P/E of 6.00 with strong 20.2% annual revenue growth, $647.9M in quarterly revenue, and $41.7M in net income, yet Vigano's divestment of virtually his entire stake signals a material shift in his ownership position regardless of valuation metrics.

10% Owner Robert M Jr Williams sells 7,000,000 shares (7.00M) for $43,680,000.00 at AVAH

Robert M Jr Williams executed three separate sales totaling 7,000,000 shares for $43,680,000.00 at $6.24 per share, reducing his holdings from 7,252,899 shares to 252,899 shares (a net change of -96.5% vs pre-transaction holdings). This near-complete liquidation of a 10% ownership stake is a material capital event. The current price of $6.66 sits -35.5% from the 52-week high of $10.32, and the stock is down -1.5% over 30 days and -7.9% over 90 days since the transaction. Across his same-ticker history at AVAH, Williams' prior 5 sales show 3 were well-timed at the 90-day mark, but this filing itself contains no FLAG indicating pre-planned scheduling, leaving the discretionary nature and timing signal of this large share reduction open to investor scrutiny.

10% owner J.H. Whitney Equity Partners VII sold 5,842,240 shares of AVAH at $6.24, reducing stake 30.3% to 13.45M shares; stock down 35.5% from 52-week high.

J.H. Whitney Equity Partners VII, a 10% shareholder, divested 5,842,240 shares at $6.24 on 2026-06-03, a material 30.3% reduction of holdings, in a market where AVAH trades at $6.66 current price—35.5% below its 52-week high of $10.32. The timing context is mixed: across the insider's cross-ticker track record, a 90-day well-timed rate of 25.00% suggests poor overall sell timing, but at AVAH specifically, 1 of 4 prior sells were well-timed at the 90-day mark. The company itself shows fundamental strength—$647.9M quarterly revenue, $41.7M net income, +20.2% annual revenue growth, and a low P/E of 6.00—providing limited evidence of operational distress. The large reduction in stake may reflect portfolio rebalancing or liquidity needs by the investor rather than a directional call on the company.

CCO Patrick A. Cunningham sold 125,000 shares of AVAH at $7.59; holdings fell 37.0% to 212.8K shares

Patrick A. Cunningham, Chief Compliance Officer, executed a substantial sale of 125,000 shares at $7.59, reducing his holdings by 37.0% to 212,755 shares. The transaction occurred when AVAH traded at $7.59, which is 25.7% below the 52-week high of $10.32, suggesting the sale happened during a mid-range price environment relative to recent history. AVAH's fundamentals show strong quarterly revenue of $647,915,000.00 with net income of $41,653,000.00 and annual revenue growth of 20.2%, alongside a low P/E of 6.91, which may reflect market undervaluation or sector headwinds. The CCO's elimination of over one-third of his position warrants monitoring of compliance risk factors and broader insider activity at the company.